Nippon India Pharma Fund (G)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund (G) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 10-May-2004 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 7,898.24 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 0.47 | 2.94 | 4.32 | -1.36 | 0.76 | 21.81 | 13.15 | 19.64 |
| Category Avg | 0.12 | 4.15 | 5.65 | -1.87 | 2.77 | 23.13 | 14.08 | 12.95 |
| Category Best | 1.05 | 6.40 | 9.18 | 3.99 | 10.45 | 27.00 | 16.62 | 26.97 |
| Category Worst | -1.31 | 1.52 | 1.63 | -5.63 | -4.02 | 18.99 | 10.38 | -7.28 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 13.92 |
| Lupin | 8.45 |
| Divi's Lab. | 6.41 |
| Dr Reddy's Labs | 5.96 |
| Cipla | 5.42 |
| Apollo Hospitals | 5.15 |
| Medplus Health | 3.86 |
| Ajanta Pharma | 3.36 |
| Max Healthcare | 3.24 |
| Sai Life | 3.15 |
| Vijaya Diagnost. | 3.15 |
| Mankind Pharma | 2.87 |
| Aurobindo Pharma | 2.81 |
| Ipca Labs. | 2.77 |
| Glaxosmi. Pharma | 2.64 |
| Abbott India | 2.43 |
| Alkem Lab | 2.17 |
| J B Chemicals & | 2.09 |
| Dr Lal Pathlabs | 2.02 |
| Thyrocare Tech. | 1.94 |
| Pfizer | 1.90 |
| Gland Pharma | 1.72 |
| Narayana Hrudaya | 1.67 |
| Emcure Pharma | 1.51 |
| Sanofi Consumer | 1.16 |
| Suraksha Diagno. | 1.12 |
| Fortis Health. | 1.11 |
| Sanofi India | 0.94 |
| Syngene Intl. | 0.93 |
| Akums Drugs | 0.89 |
| Anthem Bioscienc | 0.88 |
| Biocon | 0.67 |
| Astrazeneca Phar | 0.62 |
| Indoco Remedies | 0.38 |
| Concord Biotech | 0.14 |
| TREPS | 0.86 |
| Net CA & Others | -0.32 |
| C C I | 0.01 |



anubhai
Back Office